Comparison Chart Enlivex Deutsche Boerse AG

Stocks

1BT

IL0011319527

Delayed Deutsche Boerse AG Other stock markets 02:03:05 2026-07-20 EDT			5-day change	1st Jan Change
4.020 ^EUR	+8.65%		-31.28%	-56.77%

07-13	Enlivex Receives FDA Regenerative Medicine Advanced Therapy Designation for Allocetra in Age-Related Knee Osteoarthritis	CI
06-15	Enlivex Therapeutics Granted Patent in Australia for Allocetra to Treat Osteoarthritis	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ENLIVEX	-	+8.65%	-31.28%	-56.77%	-73.47%	-95.91%	75.21M	-	-	-